Drug: TYSABRI Injury: Immune reconstitution inflammatory syndrome Quarter: 2016Q3
Total Records: 67 Number of Pages: 4
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127871731 | TYSABRI | Immune reconstitution inflammatory syndrome | BIOGEN | 56.06 YR | F | 62 KG | 20160928 | COUNTRY NOT SPECIFIED |
127958611 | TYSABRI | Immune reconstitution inflammatory syndrome | BIOGEN | 46.33 YR | F | 0 | 20160929 | DE |
127958671 | TYSABRI | Immune reconstitution inflammatory syndrome | BIOGEN | 50.02 YR | F | 84 KG | 20160929 | DE |
127959261 | TYSABRI | Immune reconstitution inflammatory syndrome | BIOGEN | 66.00 YR | M | 0 | 20160929 | BR |
127967541 | TYSABRI | Immune reconstitution inflammatory syndrome | BIOGEN | 37.13 YR | F | 55 KG | 20160929 | IT |
1186107510 | TYSABRI | Immune reconstitution inflammatory syndrome | BIOGEN | 35.17 YR | F | 80 KG | 20160927 | ES |
1210300113 | TYSABRI | Immune reconstitution inflammatory syndrome | BIOGEN | 16.90 YR | F | 0 | 20160928 | BE |
Total Records: 67 Number of Pages: 4